Hypothalamic Atrophy and Textural Changes in Polyglutamine Ataxias

Read full text Summarise with VIRAT
Authors: Lívia Rodrigues, Thiago Junqueira Ribeiro de Rezende, Alberto RM Martinez, Breno Kazuo Massuyama, José Luiz Pedroso, Orlando G. P. Barsottini, Juan Eugenio Iglesias, Simone Appenzeller, Letícia Rittner, Marcondes C. França
Cited by: 0
References: 25

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Background. Spinocerebellar ataxia (SCA) presents a complex genetic landscape, with over 40 subtypes. These autosomal dominant disorders manifest late onset and severe disability, primarily impacting the cerebellum but also involving other nervous system structures. While a single study has linked hypothalamic atrophy to SCA3, further research is needed to confirm and/or expand this association. This study aimed to investigate hypothalamic involvement in PolyQ SCAs, focusing on SCA 1, 2, 3, and 6. Methods. We studied 135 adult patients with genetically confirmed SCA (SCA1, SCA2, SCA3, and SCA6) and 117 healthy controls. Hypothalamic subregions were segmented using H-SynEx, and both volumetric and texture features were extracted from MR images. Group differences were assessed with the Mann–Whitney U test, and associations with disease duration and severity (measured by SARA) were examined using Spearman’s rank correlation. Results. Significant atrophy of hypothalamic subregions was observed in SCA1, SCA3, and SCA6 when compared with controls, with the anterior subregion being affected in all cases. Texture analysis revealed widespread alterations in SCA1, SCA3, and SCA6 across all subregions. In SCA1 and SCA3, both volumetric and texture measures correlated with disease duration and SARA scores. These findings suggest that hypothalamic involvement in SCAs is complex and may occur before overt clinical manifestations. Key words: Ataxia, Polyglutamine disease, Hypothalamus, MRI, Volumetry

Fields of Study & Subjects

Genetic Neurodegenerative Diseases Deep Brain Stimulation and Movement Disorders Neurological diseases and metabolism

Publication details

Journal / source
The Cerebellum
Volume
25
Issue
2
Publication date
23 March 2026
Language
EN